XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.22.4

Revenue | 9 Months Ended
--- | ---
Dec. 31, 2022
Revenue From Contract With Customer [Abstract] |
Revenue | 23. REVENUE Revenue is disaggregated as follows:
|  | Three months ended |  |  | Nine months ended |
|  | December 31, |  |  | December 31, |  |  | December 31, |  |  | December 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Canada cannabis |  |  |  |  |  |  |  |  |  |  |  |
Canadian adult-use cannabis |  |  |  |  |  |  |  |  |  |  |  |
Business-to-business 1 |  | $ | 21,522 |  |  | $ | 33,282 |  |  | $ | 73,379 |  |  | $ | 117,902 |
Business-to-consumer |  |  | 11,036 |  |  |  | 14,477 |  |  |  | 36,243 |  |  |  | 48,473 |
|  |  | 32,558 |  |  |  | 47,759 |  |  |  | 109,622 |  |  |  | 166,375 |
Canadian medical cannabis 2 |  |  | 14,059 |  |  |  | 12,919 |  |  |  | 41,714 |  |  |  | 39,504 |
|  | $ | 46,617 |  |  | $ | 60,678 |  |  | $ | 151,336 |  |  | $ | 205,879 |
Rest-of-world cannabis |  |  |  |  |  |  |  |  |  |  |  |
C 3 |  |  | - |  |  |  | 9,675 |  |  |  | - |  |  |  | 33,005 |
Other rest-of-world cannabis |  |  | 5,846 |  |  |  | 12,624 |  |  |  | 30,179 |  |  |  | 32,357 |
|  | $ | 5,846 |  |  | $ | 22,299 |  |  | $ | 30,179 |  |  | $ | 65,362 |
Storz & Bickel |  | $ | 20,214 |  |  | $ | 25,205 |  |  | $ | 49,351 |  |  | $ | 63,786 |
BioSteel |  | $ | 16,363 |  |  | $ | 16,974 |  |  | $ | 64,173 |  |  | $ | 31,147 |
This Works |  | $ | 8,289 |  |  | $ | 10,730 |  |  | $ | 20,677 |  |  | $ | 26,308 |
Other |  |  | 3,884 |  |  |  | 5,086 |  |  |  | 13,475 |  |  |  | 16,073 |
Net revenue |  | $ | 101,213 |  |  | $ | 140,972 |  |  | $ | 329,191 |  |  | $ | 408,555 |
1 Canadian adult-use business-to-business net revenue during the three and nine months ended December 31, 2022 reflects excise taxes of $10,797 and $33,754, respectively (three and nine months ended December 31, 2021 – $12,754 and $43,501, respectively). 2 Canadian medical cannabis net revenue for the three and nine months ended December 31, 2022 reflects excise taxes of $1,339 and $3,625, respectively (three and nine months ended December 31, 2021 – $1,298 and $4,039, respectively). The Company recognizes variable consideration related to estimated future product returns and price adjustments as a reduction of the transaction price at the time revenue for the corresponding product sale is recognized. Net revenue reflects actual returns and variable consideration related to estimated returns and price adjustments in the amount of $8,869 and $15,345 for the three and nine months ended December 31, 2022, respectively (three and nine months ended December 31, 2021 – $3,726 and $12,375, respectively). As of December 31, 2022, the liability for estimated returns and price adjustments was $2,937 (March 31, 2022 – $3,437).

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI https://asc.fasb.org/topic&trid=49130388 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration